BioStock: Premium in Neola Medical’s directed issue

Neola Medical is in the process of establishing itself properly in the US to gear up its work with the Neola lung monitoring system. The company is now carrying out a directed share issue of 20 million SEK to finance the development and market preparations. BioStock reached out to CEO Hanna Sjöström to find out more.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/12/premium-in-neola-medicals-directed-issue/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se